Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
Exclusion Criteria:
Symptoms of cardiovascular (including, but not limited to: hypertension, stroke, chest pain, etc.), respiratory, peripheral neurological or autonomic disease (particularly diabetes mellitus requiring treatment)
Women who are pregnant or lactating
Taking or being administered a medication known to potentially have adverse interactions with phenylephrine
In the judgement of the principal investigator, any illness or condition that will interfere with the patient’s ability to comply with the protocol, compromise patient safety, or interfere with the interpretation of the study results.
Note: Other protocol defined Inclusion/Exclusion Criteria may apply.
Eligibility last updated 05/16/2025. Questions regarding updates should be directed to the study team contact.